BCR and posterior cortical atrophy: Further exploration of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases indicated that PCa patients with high PTGR1 expression had shorter biochemical recurrence (BCR)-free survival times than those with low PTGR1 expression (Fig. 5g).